GE HealthCare

GE Healthcare Technologies, Inc.
Company typePublic
IndustryHealthcare
Founded
  • September 28, 1994; 30 years ago (1994-09-28) (as a subsidiary)
  • May 16, 2022; 2 years ago (2022-05-16) (formation of corporate entity)
  • January 4, 2023; 2 years ago (2023-01-04) (spin-off from GE)
HeadquartersHeller International Building,
Chicago, Illinois
,
United States
Area served
Worldwide
Key people
RevenueIncrease US$19.7 billion (2024)
Increase US$2.63 billion (2024)
Increase US$1.99 billion (2024)
Total assetsIncrease US$33.1 billion (2024)
Total equityIncrease US$8.45 billion (2024)
Number of employees
c. 53,000 (2024)
Websitegehealthcare.com
Footnotes / references
[1]

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.[1]

The company's primary customers are hospitals and health networks.[2] In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.[2]

The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc (suburb of Paris), France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang (suburb of Beijing), China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million.[3]

In May 2022, General Electric formed the company to own its healthcare division; it completed the corporate spin-off of the company in January 2023.

  1. ^ a b "GE Healthcare Technologies Inc. Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. February 13, 2025.
  2. ^ a b Lee, Jay (September 4, 2024). "This Wide-Moat Stock Is Still a Buy Even After Recent Rally". Morningstar, Inc.
  3. ^ "The world turned upside down". The Economist. 15 April 2010.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne